Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

PFIZER

Pfizer, Inc. is the world’s largest pharmaceutical company in the world, by sales. The New York-based company produces the No. 1-selling drug, along with other widely used prescription drugs as Lipitor, Lyriuca, Diflucan, Celebrex and Viagra. This topic covers the latest news on Pfizer.

Pfizer is part of Business Exchange, suggested by Maki Yamasaki. This topic contains 1,236 news and 381 blog items. Read updated news, blogs, and resources about Pfizer. Find user-submitted articles and reactions on Pfizer from like-minded professionals.

News

Please add new articles to this topic

Pfizer Announces Detailed Results Of ORAL Sync Showing Investigational...more

Pfizer Also Presents Results of a Separate Phase 2 Trial, Study A3921109, Evaluating Atorvastatin in Patients with...

Abbott Completes Submission Of New Molecular Test Intended For Non-sma...more

gene rearrangements in non-small-cell lung cancer (NSCLC) tumors. The test is a combination product to be used with...

Reportlinker Adds A Decision Support Tool For Optimizing The Lymphoma ...more

described drug target strategies of lymphoma drugs belongs to Bristol-Myers Squibb (9), Hoffmann-La Roche (8),...

J&J AIDS Pill Signals $9 Billion in Sales to Ease Recall Woesmore

program ���among the most exciting in the industry��� and should help it outpace profit growth at drugmakers including...

GE Joins Intel to Advise Obama as Overseas Holdings Expandmore

tax earnings from U.S. operations rather than global profit. Companies including Microsoft Corp., Cisco Systems Inc.

Garden State Equality Withdraws Honors For AT&T, KPMG And Pfizer F...more

/PRNewswire/ -- Garden State Equality has voted to withdraw its honors of three national corporations, AT&T, KPMG...

Pfizer's Sutent Gets Approval To Treat Rare Cancermore

Drug cleared to treat uncommon strain that Steve Jobs had surgery for several years ago.

Pfizer Get Approval for Raw Cancer Treatmentmore

Pfizer (PFE) shares are trading to the downside Monday, despite news that the Food and Drug Administration [...]

Pfizer Announces Results From Pre-specified Sub-analysis Of EMPHASIS-H...more

Extract not available.

Adding Inspra(R) (eplerenone) To Standard Therapy Reduces The Incidenc...more

Mild Patients Hospitalization And Survival Study in Heart Failure (EMPHASIS-HF) GOTHENBURG, Sweden, May 22, 2011...

Group offers more 'uptime' for minersmore

Extract not available.

Bio-Reference Labs, Express Scripts, Pfizer: U.S. Equity Previewmore

in California and exiting its aortic stent graft business, and revising its 2011 revenue guidance to $61 million.

China Fire & Security, LeMaitre, Pfizer: U.S. Equity Previewmore

in California and exiting its aortic stent graft business, and revising its 2011 revenue guidance to $61 million.

FDA approves Sutent for rare type of pancreatic cancermore

of the mouth, and a decrease in infection-fighting white blood cells. Sutent is marketed by New York City-based Pfizer

State to invest ���10m in research centresmore

product quality, among others. It will be based at Intel, and will include Intel, Boston Scientific, Seagate, and...

Viagra 'could make you deaf'more

Viagra could make you deaf, doctors have warned.

Auxilium Pharmaceuticals, Inc. Updates Launch Progress Of XIAPEX�� In ...more

AUXL), a specialty biopharmaceutical company, today announced that the Company received a $7.5 million regulatory...

Radio Update: Stocks wrap up the week in the redmore

regulators have closed forty two banks ... and after the market close came word the FDA has approved the Pfizer drug to...

Codexis Becomes Target for Suitor Seeking Enzymes, CEO Saysmore

least 50 percent of that.��� Last year���s IPO bolstered the balance sheet and reassured pharmaceutical clients...

SUTENT��� Receives U.S. FDA Approval For Advanced Pancreatic Neuroendo...more

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SUTENT�� (sunitinib malate)...

Takeda Pays ���Upper Limit��� for Nycomed as Competition Loomsmore

June 2009. Besides Morich, who will oversee the Nycomed integration, Hasegawa hired Karen Katen, formerly vice chairman...

UPDATE 2-Bristol, Pfizer anti-clot pill wins EU approvalmore

surgery. In that study, it was compared with 30 milligrams of enoxaparin, dosed twice a day. Bristol-Myers and Pfizer,...

CORRECTED - UPDATE 1-Bristol, Pfizer anti-clot pill wins EU approvalmore

(Corrects second-to-last paragraph to show Bristol-Myers and Pfizer (not J&J) plan to unveil stroke-prevention data.

UPDATE 1-Bristol, Pfizer anti-clot pill wins EU approvalmore

undergoing knee surgery. Patients in that trial received 30 milligrams of enoxaparin, dosed twice a day.

E.U. Approves Blood Thinner From Bristol-Myers, Pfizermore

Extract not available.

Top Sources: Pfizer

  • blogs.barrons.com
  • BusinessWeek
  • knowledge.wharton.upenn.edu
  • online.wsj.com
  • MarketWatch
  • SeekingAlpha.com
  • TheStreet.com
  • Forbes.com
  • startribune.com
  • clinicaspace.com

Most Active Users in this Topic

see all contributors in Pfizer

Featured White Papers

Post a Job

Jobs in this Topic

NCBiotech Industrial Fellowship - Icagen, Inc. (Pfizer) North Carolina Biotechnology Center | Durham, NC
Posted: Apr 10
GM - Pfizer Nutrition Global Analytics Mindlance | Madison, NJ
Posted: May 26
Global Marketing Research Analyst - Pfizer Animal Health Pfizer | Madison, NJ
Posted: May 24
Pfizer-Summer Student Worker Program Kalamazoo, MI
Posted: May 20

Report comment contains invalid characters. ()
cancel
Search Cancel